Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neurologic Manifestations × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 107 Breast Neoplasms 64 Neoplasms 44 Prostatic Neoplasms 18 Obesity 14 Fatigue 13 Lung Neoplasms 11 Colorectal Neoplasms 11 Polycystic Ovary Syndrome 9 Colonic Neoplasms 8 Head and Neck Neoplasms 7 Weight Loss 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Inflammation 5 Overweight 4 Multiple Myeloma 4 Lymphedema 4 Leukemia, Myeloid, Acute 4 Leukemia 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Multiple Endocrine Neoplasia Type 1 3 Lymphoma, Follicular 3 Lymphoma 3 Insulin Resistance 3 Depression 3 Cardiotoxicity 3 Carcinoma, Non-Small-Cell Lung 3

Interventions

Bevacizumab 3 Radiosurgery 2 Irinotecan 2 pembrolizumab 1 Vorinostat 1 Valproic Acid 1 Thalidomide 1 Temozolomide 1 Surveys and Questionnaires 1 Sorafenib 1 Sildenafil Citrate 1 Pliability 1 Nivolumab 1 Morphine 1 Methadone 1 Exercise 1 Eating 1 Carboplatin 1 Amifampridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05531695 2022-09-08

ESIBAC

Hull University Teaching Hospitals NHS Trust

Phase NA Completed

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡